Joseph J. Wolk - Aug 15, 2025 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
Exec VP, CFO
Signature
/s/ Laura H. McFalls, as attorney-in-fact for Joseph J. Wolk
Stock symbol
JNJ
Transactions as of
Aug 15, 2025
Transactions value $
-$2,975,571
Form type
4
Date filed
8/18/2025, 06:19 PM
Previous filing
Feb 19, 2025
Next filing
Oct 1, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wolk Joseph J Exec VP, CFO ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK /s/ Laura H. McFalls, as attorney-in-fact for Joseph J. Wolk 2025-08-18 0001744564

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $1.71M +16.8K +120.14% $101.87 30.8K Aug 15, 2025 Direct
transaction JNJ Common Stock Sale -$2.98M -16.8K -54.57% $176.91 14K Aug 15, 2025 Direct F1
holding JNJ Common Stock 68.8K Aug 15, 2025 By SLAT F2
holding JNJ Common Stock 2.15K Aug 15, 2025 By 401k F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Employee Stock Options (Right to Buy) Options Exercise -$1.71M -16.8K -100% $101.87 0 Aug 15, 2025 Common Stock 16.8K $101.87 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $176.87 to $177.015. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 Held in a spousal lifetime access trust, of which the reporting person's spouse is the trustee and beneficiary.
F3 Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (7/31/2025).
F4 Vested and exercisable one day after the third anniversary of the date of the grant.